Literature DB >> 32456769

Early tocilizumab treatment could improve survival among COVID-19 patients.

Lluis Campins1, Ramon Boixeda2, Laia Perez-Cordon3, Raquel Aranega4, Carlos Lopera4, Lluis Force5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32456769

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  14 in total

Review 1.  Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Qi Han; Mingyue Guo; Yue Zheng; Ying Zhang; Yanshan De; Changchang Xu; Lin Zhang; Ruru Sun; Ying Lv; Yan Liang; Feng Xu; Jiaojiao Pang; Yuguo Chen
Journal:  Front Pharmacol       Date:  2020-12-15       Impact factor: 5.810

2.  Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids.

Authors:  Yi Miao; Lei Fan; Jian-Yong Li
Journal:  Front Immunol       Date:  2020-06-16       Impact factor: 7.561

Review 3.  Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.

Authors:  Rafael B Polidoro; Robert S Hagan; Roberta de Santis Santiago; Nathan W Schmidt
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

4.  High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response.

Authors:  Miguel Ángel López Zúñiga; Aida Moreno-Moral; Ana Ocaña-Granados; Francisco Andrés Padilla-Moreno; Alba María Castillo-Fernández; Dionisio Guillamón-Fernández; Carolina Ramírez-Sánchez; María Sanchez-Palop; Justo Martínez-Colmenero; María Amparo Pimentel-Villar; Sara Blázquez-Roselló; José Juan Moreno-Sánchez; María López-Vílchez; Inmaculada Prior-Sánchez; Rosario Jódar-Moreno; Miguel Ángel López Ruz
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

5.  Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.

Authors:  Jian Wu; Jiawei Shen; Ying Han; Qinghua Qiao; Wei Dai; Bangshun He; Rongrong Pang; Jun Zhao; Tao Luo; Yanju Guo; Yang Yang; Qiuyue Wu; Weijun Jiang; Jing Zhang; Mingchao Zhang; Na Li; Weiwei Li; Xinyi Xia
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 7.561

Review 6.  Cancer therapy and treatments during COVID-19 era.

Authors:  Shaw M Akula; Stephen L Abrams; Linda S Steelman; Saverio Candido; Massimo Libra; Kvin Lerpiriyapong; Lucio Cocco; Giulia Ramazzotti; Stefano Ratti; Matilde Y Follo; Alberto M Martelli; William L Blalock; Manuela Piazzi; Giuseppe Montalto; Melchiorre Cervello; Monica Notarbartolo; Jorg Basecke; James A McCubrey
Journal:  Adv Biol Regul       Date:  2020-06-26

7.  The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review.

Authors:  Avi Gurion Kaye; Robert Siegel
Journal:  PeerJ       Date:  2020-11-02       Impact factor: 2.984

Review 8.  Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?

Authors:  Eleftherios Pelechas; Vassiliki Drossou; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Mediterr J Rheumatol       Date:  2020-09-21

9.  Anakinra for severe forms of COVID-19.

Authors:  Naim Akhtar Khan
Journal:  Lancet Rheumatol       Date:  2020-08-07

10.  Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.

Authors:  John H Stone; Matthew J Frigault; Naomi J Serling-Boyd; Ana D Fernandes; Liam Harvey; Andrea S Foulkes; Nora K Horick; Brian C Healy; Ruta Shah; Ana Maria Bensaci; Ann E Woolley; Sarah Nikiforow; Nina Lin; Manish Sagar; Harry Schrager; David S Huckins; Matthew Axelrod; Michael D Pincus; Jorge Fleisher; Chana A Sacks; Michael Dougan; Crystal M North; Yuan-Di Halvorsen; Tara K Thurber; Zeina Dagher; Allison Scherer; Rachel S Wallwork; Arthur Y Kim; Sara Schoenfeld; Pritha Sen; Tomas G Neilan; Cory A Perugino; Sebastian H Unizony; Deborah S Collier; Mark A Matza; Janeth M Yinh; Kathryn A Bowman; Eric Meyerowitz; Amna Zafar; Zsofia D Drobni; Marcy B Bolster; Minna Kohler; Kristin M D'Silva; Jonathan Dau; Megan M Lockwood; Caroline Cubbison; Brittany N Weber; Michael K Mansour
Journal:  N Engl J Med       Date:  2020-10-21       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.